Navigating the newest FDA-approved medications doesn't have to be confusing
Tirzepatide is a dual GIP and GLP-1 receptor agonist, a peptide that mirrors two natural hormones your body releases after eating
16-0281-82) and cultured at 37 C in a CO 2 incubator
Tirzepatide is administered as a once-weekly subcutaneous injection, typically starting at a low dose (2.5 mg) and gradually titrated upwards over several weeks to minimise gastrointestinal side effects
I assumed that my size was genetic because the men in my mothers family are tall and heavy-set, but I also just loved food and eating, says Koo, who was born to Chinese parents in Montreal, Canada, and moved to Hong Kong permanently in 2001
The safety and effectiveness of this medication in children has not been established